iShares Health Innovation Active ETF (NYSEARCA:BMED) Short Interest Down 68.9% in February

iShares Health Innovation Active ETF (NYSEARCA:BMED) was the recipient of a significant decrease in short interest in the month of February. As of February 27th, there was short interest totaling 4,196 shares, a decrease of 68.9% from the February 12th total of 13,489 shares. Based on an average daily trading volume, of 3,392 shares, the days-to-cover ratio is currently 1.2 days. Currently, 1.3% of the company’s shares are sold short. Currently, 1.3% of the company’s shares are sold short. Based on an average daily trading volume, of 3,392 shares, the days-to-cover ratio is currently 1.2 days.

Institutional Investors Weigh In On iShares Health Innovation Active ETF

An institutional investor recently bought a new position in iShares Health Innovation Active ETF stock. Sunbelt Securities Inc. bought a new stake in shares of iShares Health Innovation Active ETF (NYSEARCA:BMED) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 11,612 shares of the company’s stock, valued at approximately $352,000. Sunbelt Securities Inc. owned approximately 3.63% of iShares Health Innovation Active ETF at the end of the most recent reporting period.

iShares Health Innovation Active ETF Stock Down 0.1%

BMED traded down $0.02 during trading hours on Wednesday, reaching $29.58. 368 shares of the company’s stock traded hands, compared to its average volume of 6,204. The firm has a 50-day moving average price of $30.86 and a 200 day moving average price of $29.25. The firm has a market capitalization of $9.47 million, a PE ratio of 24.91 and a beta of 0.84. iShares Health Innovation Active ETF has a 52-week low of $20.57 and a 52-week high of $32.19.

iShares Health Innovation Active ETF Company Profile

The BlackRock Future Health ETF (BMED) is an exchange-traded fund that is based on the MSCI All Country World index. The fund is actively managed to invest in global equities in the health sciences industry. BMED was launched on Sep 29, 2020 and is managed by BlackRock.